Abbott Sars Test

SARS-CoV-2-IgM/IgG-Test-Kit(Immunochromatographic-Assay)

EGIVD008 CE-recogniton-IVD
EUR 350
Description: CE recogniton IVD

Human IgG antibody Laboratories manufactures the abbott sars test reagents distributed by Genprice. The Abbott Sars Test reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Test. Other Abbott products are available in stock. Specificity: Abbott Category: Sars Group: Test

COX (Coxsackievirus Antibody IgG) ELISA test

96T/Box Ask for price
Description: ELISA based test for quantitative detection of COX (Coxsackievirus Antibody IgG)

RV (Rubella Antibody IgG) ELISA test

96T/Box Ask for price
Description: ELISA based test for quantitative detection of RV (Rubella Antibody IgG)

CMV (Cytomegalovirus Antibody IgG) ELISA test

96T/Box Ask for price
Description: ELISA based test for quantitative detection of CMV (Cytomegalovirus Antibody IgG)

ACA (Anticardiolipin Antibody IgG) ELISA test

96T/Box Ask for price
Description: ELISA based test for quantitative detection of ACA (Anticardiolipin Antibody IgG)

TOX (Toxoplasma Antibody IgG) ELISA test

96T/Box Ask for price
Description: ELISA based test for quantitative detection of TOX (Toxoplasma Antibody IgG)

ANA (Antinuclear Antibody IgG) ELISA test

96T/Box Ask for price
Description: ELISA based test for quantitative detection of ANA (Antinuclear Antibody IgG)

SARS-CoV-2 Rapid Antigen Test Nasal

25 Tests/Kit
EUR 112.8
Description: The SARS-CoV-2 Rapid Antigen Test is a lateral fl ow rapid chromatographic immunoassay for the qualitative detection of nucleocapsid antigen to SARS-CoV-2 present in human nasal samples. This test is intended for use as an aid in detection of SARS-CoV-2 infection in individuals suspected of COVID-19 with clinical symptoms onset within 5 days. Results are for the identification of SARS-CoV-2 nucleocapsid antigen. Antigen is generally detectable in human nasal swab samples during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co- infection with other viruses. The agent detected may not be the definite cause of disease. Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patient’s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management. The SARS-CoV-2 Rapid Antigen Test is intended for use in laboratory or POC settings by healthcare professionals, or self-collection under the supervision of a healthcare worke

Test information

HIV 1/ 2 Ab Test including sub type O.

03FK12 25 tests/kit
EUR 35.2

Panbio™ COVID-19 Ag Rapid Test Device (Nasal)

41FK11 25 Tests/Kit
EUR 128
Description: The Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 is a β -coronavirus, which is an enveloped non-segmented positive-sense RNA virus 2. It is spread by human-to-human transmission via droplets or direct contact, and infection has been estimated to have a mean incubation period of 6.4 days and a basic reproduction number of 2.24-3.58. Among patients with pneumonia caused by SARS-CoV-2, fever was the most common symptom, followed by cough3. The main IVD assays used for COVID-19 employ real-time reverse transcriptase-polymerase chain reaction (RT-PCR) that takes a few hours 4. The availability of a cost-effective, rapid point- of-care diagnostic test is critical to enable healthcare professionals to aid in the diagnosis of patients and prevent further spread of the virus5. Antigen tests will play a critical role in the fight against COVID-19

Malaria Differential P.f/Pan Ag Test (HRP II+ pLDH)

05FK60 25 tests/kit
EUR 148.5

SD Bioline HCV 25 test, duluent, acpp, lancets and swabs

02FK17CE 25 tests/kit
EUR 178.2

HIV 1/2 Ab Test including sub type O. POCT (Lancet, Capillary tube, Alcohol swab Incld.)

03FK13 1 tests/kit
EUR 60.5

Malaria Differential P.f/Pan Ag Test (HRP II+ pLDH) POCT (Lancet, Capillary tube, Alcohol swab Incld.)

05FK63 1 tests/kit
EUR 148.5

Anti-VEGFR1 / FLT1 Reference Antibody (Abbott anti-Flt1)

E24CHA586 100 μg
EUR 225
Description: Available in various conjugation types.

Anti-EPOR Reference Antibody (Abbott anti-EPO Receptor)

E24CHA210 100 μg
EUR 225
Description: Available in various conjugation types.

Alere BinaxNOW Influenza A&B Card

173-416-000 10 Tests/Kit
EUR 276

Lymphoprep

AXS-1114544 1x250 mL
EUR 75

Panbio Leptospira IgM ELISA (96w)

02PE10 96 wells/kit
EUR 456.5

Bioline HIV/Syphilis Duo

06FK30CE 20 tests/kit
EUR 288.2

Dengue IgG/IgM WB

11FK20 25 tests/kit
EUR 165

Dengue NS1 Ag

11FK50 25 tests/kit
EUR 258.5

SD Leptospira IgG/IgM Device

16FK10 30 tests/kit
EUR 151.8

SD Bioline FOB

25FK10 25 tests/kit
EUR 27.5

hCG(Urine)

30FK12 100 tests/kit
EUR 49.5